Sofinnova Investments, Inc. Iveric Bio, Inc. Transaction History

Sofinnova Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$18.67 - $24.56 $5 Million - $6.57 Million	267,584 Added 41.91%	905,982 $22 Million
Q4 2022 Feb 13, 2023	SELL	$17.24 - $23.95 $3.14 Million - $4.37 Million	-182,267 Reduced 22.21%	638,398 $13.7 Million
Q3 2022 Nov 08, 2022	BUY	$9.4 - $18.59 $1.58 Million - $3.12 Million	167,618 Added 25.67%	820,665 $14.7 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $3.36 Million - $6.96 Million	-368,164 Reduced 36.05%	653,047 $6.28 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $2.7 Million - $3.74 Million	222,422 Added 27.84%	1,021,211 $17.2 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $6.1 Million - $8.29 Million	441,389 Added 123.5%	798,789 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $2.53 Million - $6.25 Million	357,400 New	357,400 $5.8 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.